Drug information provided by: Merative, Micromedex®
SARS-CoV-2 vaccine (protein subunit, adjuvanted) is under investigation as an active immunization against COVID-19 caused by the SARS-CoV-2 virus in patients 12 years of age and older. SARS-CoV-2 (COVID-19) vaccine is used to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
This vaccine is to be given only by or under the direct supervision of your doctor.
This product is available in the following dosage forms:
Portions of this document last updated: Nov. 01, 2023
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Our $100,000 challenge is underway. Give now through Nov. 28th to double your impact on the future of healthcare.